Meeting
2023 ASCO Genitourinary Cancers Symposium
Comparison of transperineal and transrectal biopsy approaches to detect clinically significant prostate cancer in patients undergoing MRI fusion prostate biopsy: A lesion level analysis.
Authors
Andrew Wood
Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH
Andrew Wood , Prajit Khooblall , Tarik Benidir , Jennifer Bullen , Ryan Ward , Andrei Purysko , Christopher J. Weight
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Diagnostics and Imaging
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 320)
DOI
10.1200/JCO.2023.41.6_suppl.320
Abstract #
320
Poster Bd #
K18
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Contemporary diagnosis of very low risk prostate cancer in a multi-centered hospital system.
First Author: Richard Bennett IV
Poster
2023 ASCO Annual Meeting
Racial differences in the utilization of MRI-guided biopsy before prostate cancer diagnosis.
First Author: Grace L. Lu-Yao
Poster
2023 ASCO Genitourinary Cancers Symposium
Is transrectal ultrasound or magnetic resonance imaging better at estimating prostatic volume for patients with prostate cancer?
First Author: Maxwell Sandberg
Poster
2023 ASCO Genitourinary Cancers Symposium
The natural progression of patients with an IsoPSA value and its predictive ability of clinically significant prostate cancer on biopsy.
First Author: Nour Abdallah